Whittier Trust’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4K | Sell |
650
-200
| -24% | -$8.11K | ﹤0.01% | 1067 |
|
|
2025
Q1 | $37.2K | Sell |
850
-40
| -4% | -$1.75K | ﹤0.01% | 992 |
|
|
2024
Q4 | $38.2K | Hold |
890
| – | – | ﹤0.01% | 978 |
|
|
2024
Q3 | $39.5K | Hold |
890
| – | – | ﹤0.01% | 974 |
|
|
2024
Q2 | $35.4K | Hold |
890
| – | – | ﹤0.01% | 974 |
|
|
2024
Q1 | $38.4K | Sell |
890
-5
| -0.6% | -$216 | ﹤0.01% | 988 |
|
|
2023
Q4 | $37.2K | Buy |
895
+30
| +3% | +$1.25K | ﹤0.01% | 974 |
|
|
2023
Q3 | $34.4K | Buy |
865
+200
| +30% | +$7.95K | ﹤0.01% | 1003 |
|
|
2023
Q2 | $27.2K | Hold |
665
| – | – | ﹤0.01% | 1052 |
|
|
2023
Q1 | $27.3K | Hold |
665
| – | – | ﹤0.01% | 1087 |
|
|
2022
Q4 | $27.2K | Hold |
665
| – | – | ﹤0.01% | 1081 |
|
|
2022
Q3 | $27K | Hold |
665
| – | – | ﹤0.01% | 1110 |
|
|
2022
Q2 | $28K | Hold |
665
| – | – | ﹤0.01% | 1085 |
|
|
2022
Q1 | $30K | Hold |
665
| – | – | ﹤0.01% | 1101 |
|
|
2021
Q4 | $31K | Hold |
665
| – | – | ﹤0.01% | 1080 |
|
|
2021
Q3 | $32K | Buy |
665
+100
| +18% | +$4.81K | ﹤0.01% | 1027 |
|
|
2021
Q2 | $29K | Buy |
565
+200
| +55% | +$10.3K | ﹤0.01% | 1076 |
|
|
2021
Q1 | $18K | Buy |
365
+195
| +115% | +$9.62K | ﹤0.01% | 1154 |
|
|
2020
Q4 | $9K | Hold |
170
| – | – | ﹤0.01% | 1167 |
|
|
2020
Q3 | $7K | Hold |
170
| – | – | ﹤0.01% | 1188 |
|
|
2020
Q2 | $7K | Hold |
170
| – | – | ﹤0.01% | 1126 |
|
|
2020
Q1 | $6K | Buy |
170
+5
| +3% | +$176 | ﹤0.01% | 1204 |
|
|
2019
Q4 | $8K | Buy |
+165
| New | +$8K | ﹤0.01% | 1175 |
|